Skip to content

Ardelyx ARDX Deferred Tax Assets

Deferred Tax Assets at other companies

AbbVie logo
AbbVieABBV
$137M-94.7%
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
$381.4M-23.6%
Aurinia Pharmaceuticals logo
Aurinia PharmaceuticalsAUPH
$166.92M
Mineralys Therapeutics, Inc. logo
Mineralys Therapeutics, Inc.MLYS
$55.1M+254%

Other financials

Income statement

See full
Revenue$94.5M+27.5%
Gross profit$89.7M+45.1%
Operating income-$32.8M+9.8%
Net income-$37.6M+8.6%
EPS (diluted)-$0.15+11.8%

Balance sheet

See full
Cash & equivalents$31.2M+1.3%
Total debt$208.3M+34.3%
Total equity$148.6M+2.0%
Total assets$504.5M+23.0%

Cash flow

See full
Operating cash flow-$32.2M+16.2%
CapEx$69.0K-78.8%
Free cash flow-$32.3M+16.7%

Valuation

See full
Market cap$1.53B+25.5%
Enterprise value$1.71B+27.1%
P/S3.6×+0.2×

Profitability

See full
Gross margin92.5%+7.9pp
Operating margin-25.4%
Net margin-13.6%
FCF margin-40.9%

Returns & leverage

See full
Return on equity-39.5%
Debt / equity1.4×+0.3×
Current ratio3.5×-0.6×

Where this comes from

Reported directly by Ardelyx in its filing.

Tagged under the XBRL concept us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost.

The official record: Ardelyx’s 10-K, filed February 19, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ardelyx's deferred tax assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Ardelyx's deferred tax assets?
Ardelyx (ARDX) reported deferred tax assets of $13.45M in Q4 2025.
How has Ardelyx's deferred tax assets changed year-over-year?
Ardelyx's deferred tax assets increased by 19.8% year-over-year, from $11.23M to $13.45M.
What is the long-term trend for Ardelyx's deferred tax assets?
Over 5 years (2020 to 2025), Ardelyx's deferred tax assets has grown at a 19.5% compound annual growth rate (CAGR), from $5.52M to $13.45M.
What does deferred tax assets mean?
Future tax benefits from temporary differences, net operating loss carryforwards, and tax credit carryforwards that will reduce future tax payments.